What GLP-1 Medications Actually Do to Your Body GLP-1 (glucagon-like peptide-1) receptor agonists work by: Suppressing appetite and increasing feelings of fullness Slowing digestion so you feel satisfied longer Regulating blood sugar and insulin response Originally developed for type 2 diabetes, drugs like semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro) are now widely prescribed for weight loss and the WHO formally recognises them as valid obesity treatments
13 capsules: 3 mL
In assessing the complex interconnection of gut metabolites with renal and cerebrovascular endothelial dysfunction, proximal tubule dysfunction, and podocyte injury, a study found that metabolites belonging to the retinoic acid signaling and nitrogen metabolic pathways could differentiate normoalbuminuria (P1) from microalbuminuria (P2) and macroalbuminuria (P3) patients
It is created in the human brain, liver, and kidneys
Your submission has been received
This post will cover how GLP-1 medications interact with the digestive system, the potential risks for those with diverticular concerns, and how to safely approach weight management with professional guidance